Immunovant

www.immunovant.com
320 W 37th St, 6th Floor
New York, NY 10018

Company Info

Year Established
2018

Ticker
IMVT

Exchange
NASDAQ

Contacts

Eric Venker, M.D., Pharm. D
CEO

Company Description

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases.